1. Introduction {#sec1-ijerph-15-00307}
===============

Compared to studies of mortality, there are fewer studies examining the association between short-term exposure to ambient fine particulate matter (PM~2.5~) and morbidity, such as hospitalization and emergency visits \[[@B1-ijerph-15-00307],[@B2-ijerph-15-00307],[@B3-ijerph-15-00307],[@B4-ijerph-15-00307],[@B5-ijerph-15-00307],[@B6-ijerph-15-00307]\]. Multi-city studies, particularly, are scarce in the Asian region \[[@B7-ijerph-15-00307]\]. More studies in Asia, especially multi-city studies, would contribute to the comparability of air pollution-related health effects with previous studies conducted in western countries \[[@B8-ijerph-15-00307]\].

Hospitalization and emergency visits are commonly-used health indicators in reporting the association of acute morbidity and ambient air pollution. However, the database which records daily morbidity information over multiple areas for epidemiological studies has not been fully established in some countries. The use of emergency ambulance dispatches (EAD) as a morbidity indicator in studies investigating health effects of ambient air pollutants has been increasing in recent years \[[@B9-ijerph-15-00307],[@B10-ijerph-15-00307],[@B11-ijerph-15-00307],[@B12-ijerph-15-00307],[@B13-ijerph-15-00307],[@B14-ijerph-15-00307]\]. This has the potential to act as a proxy for health outcomes, especially in countries without detailed health databases. Only a few studies have examined PM~2.5~ health effects using EAD data \[[@B10-ijerph-15-00307],[@B12-ijerph-15-00307],[@B13-ijerph-15-00307],[@B14-ijerph-15-00307]\]; the others examined the health effects with PM~10~ \[[@B9-ijerph-15-00307]\] and suspended particulate matter (SPM) \[[@B11-ijerph-15-00307]\]. In addition, most of the studies estimated the association in single-city settings \[[@B10-ijerph-15-00307],[@B13-ijerph-15-00307],[@B14-ijerph-15-00307]\]. Although currently published studies using EAD data, including a study from Japan with a limited study period \[[@B12-ijerph-15-00307]\], have suggested that there are associations between PM~2.5~ and all-cause, respiratory, and cardiovascular outcomes \[[@B13-ijerph-15-00307],[@B14-ijerph-15-00307]\], there is limited evidence examining the association between PM~2.5~ and EAD due to various health outcomes in a multi-city setting.

Recent studies have reported on the effects of PM~2.5~ on cardiopulmonary outcomes \[[@B7-ijerph-15-00307]\], with the possible causal pathway linked to the underlying mechanism of systemic inflammatory responses and oxidative stress \[[@B15-ijerph-15-00307]\]. Previous studies carried out in Japan \[[@B10-ijerph-15-00307],[@B12-ijerph-15-00307]\], however, reported weak evidence of PM~2.5~ effects on cardiovascular outcomes. In addition, it was previously observed that the effects of PM~2.5~ on neuropsychological outcomes can either be acute \[[@B4-ijerph-15-00307],[@B16-ijerph-15-00307],[@B17-ijerph-15-00307]\] or prolonged \[[@B18-ijerph-15-00307],[@B19-ijerph-15-00307],[@B20-ijerph-15-00307]\], with a majority of these effects largely underestimated \[[@B21-ijerph-15-00307]\]. Pathological pathways linked to the associated PM~2.5~ effects were suggested to be facilitated through inflammatory responses, oxidative stress, microglial activation, cerebrovascular dysfunction, and alterations in the blood--brain barrier (BBB) \[[@B22-ijerph-15-00307]\].

In light of these findings, this study aimed to investigate the association of short-term exposure to ambient PM~2.5~ on EAD among different types of diagnoses in Japan. The included types of diagnoses were all-cause, cardiovascular, respiratory, cerebrovascular, and neuropsychological EAD outcomes.

2. Materials and Methods {#sec2-ijerph-15-00307}
========================

2.1. Study Area {#sec2dot1-ijerph-15-00307}
---------------

This study included data from eight cities in Japan ([Figure 1](#ijerph-15-00307-f001){ref-type="fig"}), spanning from 2007 to 2011. The eight cities are located distinctly across the northern to the southern regions. The study period of each city is shown in [Table 1](#ijerph-15-00307-t001){ref-type="table"}.

2.2. Health Data: Daily EAD {#sec2dot2-ijerph-15-00307}
---------------------------

In Japan, EAD is a free-of-charge service provided by the local fire departments, whereby the public are able to utilize the service by calling the emergency number "119" \[[@B23-ijerph-15-00307]\]. Data on daily EAD were obtained from the Fire and Disaster Management Agency of the Ministry of Internal Affairs and Communications in Japan. EAD data for Kumamoto city were later obtained from its city office. The data contained information on sex, age category, cause of dispatches, type of diagnoses, and the severity of the patient's condition. To avoid the inclusion of health outcomes irrelevant to the main exposure, among the 14 categories for the cause of dispatches, only the category "acute illnesses" (referring to non-traumatic or non-accidental health outcome) was extracted and used for the analyses in this study. Meanwhile, primary diagnoses were determined by emergency medical doctors upon arrival at the hospital and were coded into 10 major categories (cardiovascular, respiratory, cerebrovascular, digestive, psychiatric, nerves and sensory, urological, neoplasms, others, and unknown), defined by the International Classification of Diseases, Tenth Revision (ICD-10). We further examined the association between ambient PM~2.5~ and EAD for all-cause acute illnesses (i.e., all diseases except traumatic cases), and included only EAD for cardiovascular (ICD-10: I10--I15, I20--I25, I01--I02.0, I05--I09, I27, I30--I52), respiratory (ICD-10: J00--J99), cerebrovascular (ICD-10: I63, I69.3, I60--I62, I64--I68, I69.0--I69.2, I69.4--I69.8) and neuropsychological (ICD-10: F00--F99, G00--G99, H00--H59, H60--H95) outcomes for cause-specific analyses. This study was approved by the Ethics Committee of the Kyoto University Graduate School of Engineering (No. 201410).

2.3. Environmental Data {#sec2dot3-ijerph-15-00307}
-----------------------

Hourly concentrations of ambient PM~2.5~ and gaseous pollutants (nitrogen dioxide (NO~2~), photochemical oxidants (O~x~) and sulfur dioxide (SO~2~)) monitored at one background monitoring station of each city, were obtained from the National Institute for Environmental Studies (NIES). Ambient PM~2.5~ were measured using monitors that employ tapered element oscillating microbalances (TEOM) in all cities except Osaka and Saitama. Data for Osaka were based on a combination of beta ray attenuation (1 January 2008--31 March 2009) and TEOM (1 April 2009--31 December 2011). Ambient PM~2.5~ data for Saitama were obtained from the Center for Environmental Science in Saitama, based on daily filter sampling. O~x~ comprises ozone and peroxyacetyl nitrate generated by photochemical reactions (only those capable of isolating iodine from neutral potassium iodide, excluding nitrogen dioxide). Weather data (ambient temperature and relative humidity) were obtained from the Japan Meteorological Agency. Daily 24-h average concentration was calculated for each pollutant. We excluded the days which consisted of more than four missing hourly concentrations of PM~2.5~.

Data on influenza epidemics were obtained from the Japan National Institute of Infectious Diseases. A week was defined as an influenza epidemic week, when the influenza cases within that week were more than the 90th percentile of the total distribution throughout the study period \[[@B24-ijerph-15-00307]\].

2.4. Statistical Analyses {#sec2dot4-ijerph-15-00307}
-------------------------

A two-stage analysis was conducted to estimate the relative risks of EAD associated with exposure to PM~2.5~. This included all-cause and cause-specific (cardiovascular, respiratory, cerebrovascular, and neuropsychological) EAD, and consisted of a sensitivity analysis stratifying all-cause EAD by different age groups. During the first stage, we investigated the city-specific association between ambient PM~2.5~ and daily EAD for acute illnesses, using a generalized linear model (GLM) based on a Poisson distribution. We included the following covariates, tested as per the following order: calendar date, daily mean temperature, relative humidity, public holiday, day-of-week, and influenza epidemic. The models were decided based on a model simplification approach, whereby the simpler model would be retained if the *p*-value from the *Chi-square* test of ANOVA in comparing the models was less than 0.05. A natural cubic spline was applied to calendar time to allow smooth modelling for the long-term and seasonal patterns, with 7 degrees of freedom (df) per year \[[@B25-ijerph-15-00307]\], as well as for the daily mean ambient temperature (averaged from the current day to 3 days before), with 3 df \[[@B26-ijerph-15-00307]\]. Public holidays and day-of-week were adjusted for all cities as indicator variables. Since there was no significant difference between the models with or without relative humidity, it was not included in the model for all cities. The same applied for the influenza epidemics; it was adjusted only in Sapporo and Osaka as an indicator variable.

The lagged effect of ambient PM~2.5~ was examined via an unconstrained, distributed structure, with an extension of 7 days (lag 0 to lag 7), and average structure (using average of PM~2.5~ over lag-days: lag 0--1, lag 0--3, lag 0--5 and lag 0--7) (hereafter referred to as "average lag"). The models were used to estimate the relative risk of EAD for acute illnesses per 10 µg/m^3^ increase in ambient PM~2.5~.

During the second stage, a random-effects meta-analysis was utilized to obtain the pooled effect estimates of ambient PM~2.5~ on EAD. An *I*^2^ statistic was used to estimate the amount of heterogeneity, while applying the Chi-square test from Cochran's Q statistic to test the significance of heterogeneity \[[@B27-ijerph-15-00307]\].

To examine the robustness of the association, we applied two-pollutant models and included each gaseous pollutant in the main model one at a time. We also changed the df for calendar time (df ranged from 3 to 13) and temperature (df ranged from 4 to 8). An additional analysis was conducted with bootstrapping, utilizing 10,000 simulations to obtain the empirical estimates and confidence intervals of our results, using the estimates of all-cause EAD at lag 0--1.

All statistical analyses were conducted in R (version 3.1.1, The R Foundation for Statistical Computing, Vienna, Austria) utilizing the R packages *splines* \[[@B28-ijerph-15-00307]\] and *metafor* \[[@B29-ijerph-15-00307]\]. All results were presented as the percent change (Equation (1)) of EAD with 95% confidence interval (95% CI) per 10 µg/m^3^ increase in ambient PM~2.5~. Statistical significance was considered when the *p*-value was less than 0.05. $${Percent}\ {change} = \left( {exp^{estimate} - 1} \right) \times 100\%$$

3. Results {#sec3-ijerph-15-00307}
==========

A total of 1,114,515 cases of EAD for acute illnesses in the eight cities from 2007 to 2011 were included in this study. [Table 1](#ijerph-15-00307-t001){ref-type="table"} shows the daily average number of EAD in each city during each study period, with the lowest in Kumamoto (x̅ = 43) and highest in Osaka (x̅ = 305). Data on sex in Nagoya, Osaka, and Hiroshima were not available. Males and females were found to be almost equally distributed. The number of EAD for acute illnesses generally consisted of more elderly than children and adults. [Table 2](#ijerph-15-00307-t002){ref-type="table"} shows the daily average value of environmental variables. The daily mean PM~2.5~ concentration ranged from 11.3 µg/m^3^ (Sapporo) to 20.8 µg/m^3^ (Hiroshima). The daily mean temperature was lowest in Sapporo (8.4 °C), while in other cities it ranged from 12.2 °C (Sendai) to 18.3 °C (Kumamoto). Tukey's test showed that there were significant differences between cities, particularly lower PM~2.5~ concentrations and temperature in the northern cities (such as Sapporo and Sendai), compared to the other cities ([Table S3](#app1-ijerph-15-00307){ref-type="app"}).

[Figure 2](#ijerph-15-00307-f002){ref-type="fig"} shows the city-specific estimates of all-cause EAD associated with PM~2.5~ from lag 0 to lag 7. In general, the highest risks of all-cause EAD were mostly observed on the current day (lag 0), especially in the cities with a larger population, i.e., Saitama, Nagoya, Osaka and Fukuoka. Pooled results for the single-day lags showed an increased risk at lag 0 (1.24% (95% CI: 0.92, 1.56)) followed by a decline at lag 1 (−0.47% (95% CI: −0.80, −0.14)) ([Figure 3](#ijerph-15-00307-f003){ref-type="fig"}a). As for the average lags, an increase in EAD risk was observed at lag 0--1 (0.64% (95% CI: 0.23, 1.06)) while the effect estimates decreased at the latter lags ([Figure 3](#ijerph-15-00307-f003){ref-type="fig"}b).

Cause-specific EAD outcomes due to short-term exposure to ambient PM~2.5~ are shown in [Table 3](#ijerph-15-00307-t003){ref-type="table"}. Our study showed significant increases of respiratory (1.88% (95% CI: 1.00, 2.76)) and neuropsychological (1.48% (95% CI: 0.69, 2.28)) EAD, both at lag 0. On the other hand, significant average lag effects were observed only in the respiratory outcomes (extending up to 5 days), but not in the neuropsychological outcomes. The risk of respiratory outcomes was highest at lag 0--3 (2.79% (95% CI: 1.31, 4.29)). There was no significant effect on cardiovascular outcomes, while an inverse association was observed in cerebrovascular outcomes. We observed heterogeneity at some lags but not for all categories ([Table S4](#app1-ijerph-15-00307){ref-type="app"}).

Age-stratified results ([Table 4](#ijerph-15-00307-t004){ref-type="table"}) showed significantly increased effect estimates of all-cause EAD associated with PM~2.5~ at lag 0 in all age categories which did not differ largely among each other (children: 1.24% (95% CI: 0.21, 2.27); adults: 1.29% (95% CI: 0.87, 1.71); elderly: 1.19% (95% CI: 0.75, 1.62)). The effect estimates became smaller at the latter lags. Significantly increased effect estimates were observed in average lags for the adults (0.78% (95% CI: 0.25, 1.32) at lag 0--1) and for the elderly (0.65% (95% CI: 0.20, 1.11) at lag 0--1 and 0.61% (95% CI: 0.16, 1.07) at lag 0--3). The effect estimates of EAD for all acute illnesses remained robust in models using different df on calendar date ([Table S1](#app1-ijerph-15-00307){ref-type="app"}) and on temperature ([Table S2](#app1-ijerph-15-00307){ref-type="app"}), as well as in the two-pollutant model ([Figure 4](#ijerph-15-00307-f004){ref-type="fig"}). Although there was a drop in the +SO~2~ model, the estimate remained within the 95% confidence interval of the single pollutant model, thus the drop was not significant. Nonetheless, the drop might suggest a confounding effect of SO~2~ on the association between PM~2.5~ and EAD outcomes. After bootstrapping with 10,000 simulations, the empirical estimates showed that the association between PM~2.5~ and health outcomes would always remain positive (all-cause EAD at lag 0--1: 0.49% (95% CI: 0.02, 0.98)).

4. Discussion {#sec4-ijerph-15-00307}
=============

In this multi-city study, we found that short-term exposure to ambient PM~2.5~ was associated with increased risks of all-cause EAD in immediate lags (lag 0 and lag 0--1). Cause-specific analyses showed that significant associations were observed in the EAD for respiratory and neuropsychological outcomes. While the positive association persisted for longer lags and was largest at lag 0--3 for respiratory EAD, the association for neuropsychological outcomes disappeared at the latter lags.

Across cities, the PM~2.5~ levels were significantly different. PM~2.5~ levels in the northern part of Japan (Sapporo and Sendai) were generally lower than those of other cities, with the daily mean concentrations below the Japanese air quality standards for PM~2.5~ (15 µg/m^3^). Increases in EAD were observed mostly in cities with daily PM~2.5~ levels exceeding 15 µg/m^3^. However, whether the differences in PM~2.5~ levels across cities explain heterogeneity across cities requires further investigations.

It has been suggested that exposure to ambient PM~2.5~ contributes to increased risk of all-cause EAD \[[@B10-ijerph-15-00307],[@B13-ijerph-15-00307]\], cardiovascular, and cerebrovascular hospitalizations \[[@B1-ijerph-15-00307],[@B2-ijerph-15-00307],[@B3-ijerph-15-00307],[@B30-ijerph-15-00307]\]. However, we observed non-conventional yet noteworthy results, such as the statistically insignificant association of PM~2.5~ on cardiovascular EAD outcomes, and an inverse association with cerebrovascular EAD outcomes. Also, the effect estimates of PM~2.5~ on EAD did not vary largely among age categories.

We found that the effect of ambient PM~2.5~ was significant in respiratory outcomes but not in cardiovascular outcomes. This is consistent with findings reported in previous studies \[[@B2-ijerph-15-00307],[@B31-ijerph-15-00307],[@B32-ijerph-15-00307]\], though one paper emphasized the effect modification by PM~2.5~ components \[[@B31-ijerph-15-00307]\]. Another paper reported that ambient PM~2.5~ increased the risk for various acute respiratory outpatient visits, including upper respiratory tract infections, acute bronchitis, community-acquired pneumonia, and acute exacerbation of bronchiectasis \[[@B32-ijerph-15-00307]\]. Since the respiratory system is among the first to be exposed and injured upon exposure to ambient PM~2.5~, the pathophysiological pathway of its effects may lead to systemic damages. Earlier studies suggested that particulate exposure could lead to cell injury due to oxidative stress \[[@B33-ijerph-15-00307]\], inflammatory responses \[[@B34-ijerph-15-00307]\], and imbalanced intracellular calcium homeostasis \[[@B35-ijerph-15-00307]\]. These pro-inflammatory conditions due to exposure to air pollutant could be underlying mechanisms for other diseases such as cardiovascular and neuropsychological outcomes.

The number of studies focusing on the association of air pollution with neuropsychological outcomes have increased in recent years, as inflammation and oxidative stress caused by air pollution are thought to cause neurotoxic effects \[[@B17-ijerph-15-00307],[@B18-ijerph-15-00307],[@B20-ijerph-15-00307]\]. There are several possible pathways to the brain: (1) direct transportation of pollutant via circulatory pathway to the brain, passing through the BBB; (2) systemic inflammation whereby cytokines were circulated to the brain; and (3), the nose-to-brain route that bypasses the protective BBB whereby pollutants are transported along the olfactory nerve to the brain \[[@B36-ijerph-15-00307]\], prior to the underlying toxicity mechanisms such as inflammation, microglial activation \[[@B37-ijerph-15-00307]\], oxidative stress, and neuronal death \[[@B38-ijerph-15-00307]\]. A few recent studies found that long-term exposure to ambient PM~2.5~ was associated with increased risks in Alzheimer's disease, Parkinson's disease \[[@B18-ijerph-15-00307]\], dementia \[[@B18-ijerph-15-00307],[@B19-ijerph-15-00307]\] and memory loss \[[@B20-ijerph-15-00307]\]. There are also studies reporting the positive association between short-term exposure to PM~2.5~ and Parkinson's disease \[[@B4-ijerph-15-00307],[@B16-ijerph-15-00307]\] and headache \[[@B17-ijerph-15-00307]\]. Interestingly, Chen et al. (2015) \[[@B39-ijerph-15-00307]\] found increased clinic visits for migraine associated with ambient PM~2.5~ on warm days but not on cold days.

The statistically insignificant result exhibited by the cardiovascular outcomes in our study is similar to those reported in the previous studies carried out in Japan \[[@B10-ijerph-15-00307],[@B12-ijerph-15-00307]\]. Pulmonary inflammation leads to pathways, including systemic inflammatory responses, an increase in blood coagulation factors, and an imbalanced autonomic reflex which interferes with the hearth rhythm control \[[@B15-ijerph-15-00307]\]. Ichiki et al. (2016) suggested that the possibility of the effect attenuation was due to the inclusion of a wide range of age or a lower incidence of underlying ischemic heart diseases in Japan, compared to Western countries \[[@B12-ijerph-15-00307]\]. In Sajani et al. (2014), PM~10~-related all-cause EAD was higher when compared with all-cause mortality, with cardiovascular and respiratory EAD being lower when compared to that of mortality and hospital admissions \[[@B9-ijerph-15-00307]\]. Further investigations would be necessary to determine whether the use of EAD underestimates certain types of disease or misclassifies study populations.

In contrast with previous findings regarding the effects of ambient PM~2.5~ on cerebrovascular outcomes \[[@B40-ijerph-15-00307],[@B41-ijerph-15-00307]\], our study observed inverse associations, especially on average lags. There are three possibilities which could explain this situation. The first possibility is that the effect was too acute, or that the frail population was too weak, that the incidence rate was lower than the fatality rate, causing a low prevalence in the study population \[[@B42-ijerph-15-00307]\]. On the other hand, it could be due to the harvesting effect, which is also known as the displacement of a health outcome (in this study, EAD displacement). Wellenius et al. (2012) \[[@B30-ijerph-15-00307]\] reported a 12-h lag in PM~2.5~ on stroke onset, instead of a per-day lag. If stroke is triggered within 24 h, the use of a per-day lag might attenuate the effect estimates ([Figure S1](#app1-ijerph-15-00307){ref-type="app"}). The third possibility is the displacement of the frail population into other categories. In mortality studies, double-counting of cases is not a concern. Thus, in observing mortality displacement, category displacement would not be an issue. In the utilization of EAD as a health indicator, category displacement could be an issue, in addition to the over-time morbidity displacement. This is possible as cerebrovascular patients could have complications, such as recurrent stroke, seizure, pain, anxiety depression, or infection \[[@B43-ijerph-15-00307],[@B44-ijerph-15-00307]\]. Assuming that long-term exposure to ambient PM~2.5~ has predisposed an individual to a morbid condition, the partial effects observed here might be due to the harvesting effect, even if it is not a total attribute. This would also explain the insignificance of observations in cardiovascular outcomes in our study. These, however, require further investigation.

The lag pattern observed in the current study is consistent with the hypothesized pattern of the harvesting effect, whereby a drop follows an initial increase. Although the drops were significant, as observed in [Figure 3](#ijerph-15-00307-f003){ref-type="fig"}a and [Figure S1](#app1-ijerph-15-00307){ref-type="app"}, the pattern of a drop following the initial increase reflected the possibility that health outcomes were brought forward in time. In other words, if the initial increase was counterbalanced by the drop, there is a harvesting effect in the association being observed. Otherwise, a second increase would follow for the drop, whereby all three parts throughout the lags could provide an overview of the association---air pollution does not only harvest (displace) frail populations, but also increases the pool size of frail populations \[[@B45-ijerph-15-00307]\].

This study has several strengths. First, the multi-city analysis allowed a representative overview of the association between ambient PM~2.5~ and various health outcomes. There were significant differences of environmental variables between cities ([Table S3](#app1-ijerph-15-00307){ref-type="app"}), thus pooling the effect estimates covering the geologically distinct locations improved the representativeness of the observed health effects of PM~2.5~. Although another study focusing on cardiovascular disease in Japan included over 30 prefectures, it only included data over 9 months \[[@B12-ijerph-15-00307]\], whereas our study spanned a longer period. Evidence of adverse effects of short-term exposure to ambient PM~2.5~ on EAD for all-cause, respiratory, and neuropsychological outcomes in Japan was added to the literature. Second, we explored the 7-day lag structure, which allowed us to observe potential harvesting effects as well as average effects in different health outcomes. Third, our study indicated the usefulness of EAD as an indicator, which reflects an acute onset of medical conditions. Although EAD has not been used until recently, establishing the consistency and reliability of EAD as a health indicator is important for future studies in countries where other health data are difficult to obtain.

Nonetheless, we would like to acknowledge some limitations in our study. First, the diagnosis for each dispatch was confirmed by a medical doctor upon arrival of the dispatch. This might misclassify the exact medical condition which would be diagnosed afterwards. It is not possible for us to detect the misclassification, if there is any, as our data did not include any individual information. Second, exposure to ambient PM~2.5~ might have been misclassified as our data could not represent the actual personal exposure for each individual. Furthermore, air pollutant data was obtained from one monitoring station in each city. Third, the EAD data contained general categories of diagnoses. Although it is useful in providing a generalizable and representative observation on the study population, it could not show the effect on specific types of disease from each category of diagnoses. For example, the EAD data could provide a population within the category of respiratory outcomes, but it could not distinguish between specific types of respiratory outcomes, such as bronchitis, asthma, or chronic obstructive pulmonary disease. Finally, more recent data were not available, despite efforts trying to update it. More recent data might contribute additional information, although it may not significantly alter the slope of the risk.

5. Conclusions {#sec5-ijerph-15-00307}
==============

In conclusion, short-term exposure to ambient PM~2.5~ increased the risk of EAD for all-cause, respiratory, and neuropsychological outcomes. The effects observed were generally acute, occurring within the first 2 days. Average lag effects were observed only in respiratory outcomes, extending up to lag 0--3. No significant association was observed in cardiovascular outcomes, while inverse associations were observed in cerebrovascular outcomes.
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ijerph-15-00307-t001_Table 1

###### 

Daily average number of emergency ambulance dispatches (EAD) in each city during the study period.

  Characteristics      Sapporo                         Sendai                          Saitama                       Nagoya                             Osaka                              Hiroshima                        Fukuoka                            Kumamoto
  -------------------- ------------------------------- ------------------------------- ----------------------------- ---------------------------------- ---------------------------------- -------------------------------- ---------------------------------- --------------------------------
  **Study period**     1 January 2007--31 March 2010   1 January 2007--31 March 2010   1 April 2009--31 March 2011   1 January 2008--31 December 2011   1 January 2008--31 December 2011   1 April 2010--31 December 2011   1 January 2009--31 December 2011   1 April 2010--31 December 2011
  **Population \***    1,913,545                       1,045,986                       1,222,434                     2,263,894                          2,665,314                          1,173,843                        1,463,743                          734,474
  **Sex**                                                                                                                                                                                                                                                      
   Male                53 (9)                          28 (6)                          46 (9)                        NA                                 NA                                 NA                               46 (8)                             21 (5)
   Female              58 (9)                          27 (6)                          41 (8)                        NA                                 NA                                 NA                               47 (8)                             22 (5)
  **Age**                                                                                                                                                                                                                                                      
   Children            8 (4)                           4 (2)                           8 (4)                         9 (5)                              21 (7)                             6 (3)                            7 (3)                              3 (2)
   Adult               53 (9)                          24 (5)                          37 (8)                        66 (12)                            142 (18)                           31 (7)                           43 (8)                             18 (4)
   Elderly             51 (8)                          27 (6)                          41 (9)                        84 (15)                            142 (19)                           38 (7)                           43 (8)                             23 (5)
  **Diagnosis type**                                                                                                                                                                                                                                           
   All acute illness   111 (14)                        55 (9)                          86 (14)                       159 (22)                           305 (33)                           74 (11)                          93 (13)                            43 (8)
   Cardiovascular      14 (4)                          4 (2)                           4 (2)                         15 (4)                             31 (6)                             10 (3)                           9 (3)                              3 (2)
   Respiratory         12 (5)                          5 (2)                           5 (2)                         18 (5)                             32 (7)                             10 (3)                           12 (4)                             3 (1)
   Cerebrovascular     18 (6)                          5 (2)                           5 (2)                         11 (4)                             25 (5)                             12 (4)                           24 (5)                             3 (2)
   Neuropsychology     12 (4)                          5 (2)                           6 (3)                         14 (4)                             53 (9)                             10 (3)                           5 (2)                              3 (2)

\* Population based on Japanese census in 2010. Values are shown as the daily mean (standard deviation). Note: Data on the sex category were not available in Nagoya, Osaka, nor Hiroshima.

ijerph-15-00307-t002_Table 2

###### 

Daily average concentration of environmental variables in each city during the study period.

  -----------------------------------------------------------------------------------------------------------
  Environmental Variable   Sapporo   Sendai    Saitama   Nagoya    Osaka     Hiroshima   Fukuoka   Kumamoto
  ------------------------ --------- --------- --------- --------- --------- ----------- --------- ----------
  PM~2.5~ (µg/m^3^)        11.27\    12.41\    17.86\    16.00\    18.58\    20.84\      18.14\    18.73\
                           (5.71)    (6.59)    (11.76)   (8.42)    (9.90)    (12.32)     (10.31)   (12.96)

  SO~2~ (ppb)              2.27\     0.59\     1.33\     1.83\     5.22\     1.24\       1.77\     3.41\
                           (1.57)    (0.58)    (0.62)    (1.18)    (2.97)    (0.86)      (1.19)    (1.56)

  NO~2~ (ppb)              15.53\    13.83\    18.78\    20.83\    20.23\    13.82\      13.46\    9.77\
                           (9.78)    (6.09)    (7.58)    (7.72)    (9.09)    (6.44)      (7.35)    (4.92)

  O~x~ (ppb)               27.58\    29.17\    28.47\    24.70\    29.00\    27.60\      29.45\    26.37\
                           (11.15)   (11.62)   (13.34)   (12.86)   (13.21)   (12.98)     (13.44)   (12.15)

  Temperature (°C)         8.64\     12.19\    15.52\    16.43\    17.08\    17.69\      17.35\    18.34\
                           (9.31)    (8.00)    (8.62)    (8.56)    (8.35)    (8.57)      (8.05)    (8.31)

  Relative humidity (%)    67.92\    71.48\    65.06\    63.50\    62.76\    64.53\      65.58\    69.33\
                           (10.23)   (13.00)   (13.84)   (12.35)   (10.98)   (10.33)     (11.96)   (10.84)
  -----------------------------------------------------------------------------------------------------------

Values are shown as daily mean (standard deviation).
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###### 

Pooled effect of ambient PM~2.5~ on cause-specific EAD outcomes.

  Lag Structure      Cardiovascular        Respiratory            Cerebrovascular           Neuropsychology
  ------------------ --------------------- ---------------------- ------------------------- ----------------------
  Lag 0 ^a^          0.36 (−1.30, 2.05)    1.88 (1.00, 2.76) \*   0.24 (−0.62, 1.11)        1.48 (0.69, 2.28) \*
  **Average lags**                                                                          
  Lag 0--1           −0.10 (−0.92, 0.73)   2.47 (1.69, 3.26) \*   −1.76 (−2.80, −0.72) \*   0.59 (−1.09, 2.30)
  Lag 0--3           −0.19 (−1.47, 1.11)   2.79 (1.31, 4.29) \*   −1.27 (−2.22, −0.32) \*   1.03 (−1.71, 3.84)
  Lag 0--5           −0.20 (−1.37, 0.98)   1.86 (0.23, 3.51) \*   −1.13 (−2.23, −0.02) \*   0.06 (−2.50, 2.68)
  Lag 0--7           −0.60 (−1.90, 0.72)   1.53 (−0.07, 3.16)     −1.05 (−2.29, 0.19)       −0.30 (−2.71, 2.17)

Values were shown as percent change (95% CI). ^a^ Lag 0 of unconstrained, distributed lag model. \* Statistical significance at *p* \< 0.05.
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###### 

Pooled effect of ambient PM~2.5~ on all-cause EAD by age category.

  Lag Structure      Children (Age below 18 Years)   Adult (Age 18 to 64 Years)   Elderly (Age 65 Years and above)
  ------------------ ------------------------------- ---------------------------- ----------------------------------
  Lag 0 ^a^          1.24 (0.21, 2.27) \*            1.29 (0.87, 1.71) \*         1.19 (0.75, 1.62) \*
  **Average lags**                                                                
  Lag 0--1           0.89 (−0.09, 1.89)              0.78 (0.25, 1.32) \*         0.65 (0.20, 1.11) \*
  Lag 0--3           1.09 (−0.14, 2.32)              0.55 (−0.37, 1.48)           0.61 (0.16, 1.07) \*
  Lag 0--5           0.45 (−0.96, 1.88)              0.16 (−0.99, 1.33)           0.34 (−0.36, 1.05)
  Lag 0--7           0.03 (−1.53, 1.61)              0.26 (−0.93, 1.47)           0.05 (−0.73, 0.84)

Values are shown as percent change (95% CI). ^a^ Lag 0 of unconstrained, distributed lag model. \* Statistical significance at *p* \< 0.05.
